These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 6692543)

  • 1. Rapid quantification of pentobarbital in serum by fluorescence polarization immunoassay.
    Li PK; Lee JT; Schreiber RM
    Clin Chem; 1984 Feb; 30(2):307-8. PubMed ID: 6692543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid estimation of plasma pentobarbital levels by an enzyme immunoassay for barbiturates (EMIT).
    Wellington P; Rutkowski RB
    Ther Drug Monit; 1982; 4(3):319-22. PubMed ID: 6753256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pentobarbital quantification in the presence of phenobarbital by fluorescence polarization immunoassay.
    Earl R; Sobeski L; Timko D; Markin R
    Clin Chem; 1991 Oct; 37(10 Pt 1):1774-7. PubMed ID: 1914183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the serum barbiturate fluorescence polarization immunoassay by the COBAS INTEGRA to a GC/MS method.
    Cannon RD; Wong SH; Gock SB; Jentzen JJ
    Ther Drug Monit; 1999 Oct; 21(5):553-8. PubMed ID: 10519455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pentobarbital quantitation using immunoassays in Reye's syndrome patient serum.
    Turley CP
    Ther Drug Monit; 1989; 11(3):343-6. PubMed ID: 2728092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pentobarbital quantitation using EMIT serum barbiturate assay reagents: application to monitoring of high-dose pentobarbital therapy.
    Pape BE; Cary PL; Clay LC; Godolphin W
    Ther Drug Monit; 1983; 5(4):467-71. PubMed ID: 6362100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a rapid immunoassay for monitoring serum pentobarbital concentrations.
    Karnes HT; Iafrate RP; Gudat JC; Hendeles L
    Am J Hosp Pharm; 1984 Dec; 41(12):2642-6. PubMed ID: 6393759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorescence polarization immunoassay evaluated for screening for amphetamine and methamphetamine in urine.
    Caplan YH; Levine B; Goldberger B
    Clin Chem; 1987 Jul; 33(7):1200-2. PubMed ID: 3297420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of norvancomycin fluorescence polarization immunoassay for therapeutic drug monitoring.
    Wu XJ; Zhang J; Yu JC; Cao GY; Shi YG; Zhang YY; Wang MG
    J Antibiot (Tokyo); 2012 Jan; 65(1):35-9. PubMed ID: 22045420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Drug Monitoring of Pentobarbital: Experience at an Academic Medical Center.
    Humble RM; Ehlers A; Pakalniskis BL; Morris C; Drees D; Kulhavy J; Krasowski MD
    Ther Drug Monit; 2015 Dec; 37(6):783-91. PubMed ID: 26565790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescence polarization immunoassay for the determination of therapeutic drug levels in human plasma.
    Jolley ME
    J Anal Toxicol; 1981; 5(5):236-40. PubMed ID: 7321548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Emit tox benzodiazepine and barbiturate assays on the Vitalab Viva analyser and FPIA on the Abbott ADx analyser.
    Charlier CJ; Plomteux GJ
    Clin Chem Lab Med; 2000 Jul; 38(7):615-8. PubMed ID: 11028766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of fluorescence polarization immunoassay and high performance liquid chromatography for the quantitative determination of phenytoin, phenobarbitone and carbamazepine in serum.
    Ashy AR; el-Sayed YM; Islam SI
    J Pharm Pharmacol; 1986 Aug; 38(8):572-7. PubMed ID: 2876072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinical trial for therapeutic drug monitoring using microchip-based fluorescence polarization immunoassay.
    Tachi T; Hase T; Okamoto Y; Kaji N; Arima T; Matsumoto H; Kondo M; Tokeshi M; Hasegawa Y; Baba Y
    Anal Bioanal Chem; 2011 Oct; 401(7):2301-5. PubMed ID: 21837465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorescence polarization immunoassay for theophylline modified for use with dried blood spots on filter paper.
    Li PK; Lee JT; Conboy KA; Ellis EF
    Clin Chem; 1986 Mar; 32(3):552-5. PubMed ID: 3948405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spurious phenobarbital levels by fluorescence polarization immunoassay using TDx analyzer in patients with renal disease.
    Bridges RR; Jennison TA
    Ther Drug Monit; 1984; 6(3):368-70. PubMed ID: 6390800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microchip-based homogeneous immunoassay using fluorescence polarization spectroscopy.
    Tachi T; Kaji N; Tokeshi M; Baba Y
    Lab Chip; 2009 Apr; 9(7):966-71. PubMed ID: 19294309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of digoxin analysis by high-performance liquid chromatography/post-column derivatization and fluorescence polarization immunoassay.
    Embree L; McErlane KM
    Xenobiotica; 1990 Jun; 20(6):635-43. PubMed ID: 2219957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Abbott TDx fluorescence polarization immunoassay, Sandoz radioimmunoassay, and high-performance liquid chromatography methods for the assay of serum cyclosporine.
    Schroeder TJ; Pesce AJ; Hassan FM; Wermeling JR; Warner A; Schlueter KT; First MR
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):345-7. PubMed ID: 3284078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liquid chromatography and fluorescence polarization immunoassay methods compared for measuring flecainide acetate in serum.
    Straka RJ; Hoon TJ; Lalonde RL; Pieper JA; Bottorff MB
    Clin Chem; 1987 Oct; 33(10):1898-900. PubMed ID: 3117433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.